600161 Beijing Tiantan Biological Products Corporation
- 20.77
- +0.06+0.29%
About Beijing Tiantan Biological Products Corporation Company
The company was listed in 1998, and its main business is R&D, manufacturing, sales and consulting services for blood products. After two major asset restructuring in 2010 and 2017, it became a specialized blood products operating company of China Biotechnology Co., Ltd. The company's main business is to develop and produce blood products using healthy human plasma or healthy human plasma that has undergone specific immunization as raw materials and uses genetic recombination technology to develop and produce blood products business. The company's main products include human blood albumin, intravenous human immunoglobulin (pH4), tetanus immunoglobulin, rabies patient immunoglobulin, human hepatitis B human immunoglobulin, freeze-dried intravenous hepatitis B human immunoglobulin (pH4), human immunoglobulin, histamine human immunoglobulin, human thrombin complex, human clotting factor VIII, human fibrinogen, etc. Corporate honors: 2017 High-tech Enterprise, Sichuan Famous Brand Product Title, Beijing Biomedical Industry Leap Development Project (G20 Project), Advanced Standard Research Unit for the 2010 Edition of the Chinese Pharmacopeia, Innovative Enterprise in Zhongguancun National Independent Innovation Demonstration Zone, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- huichuan yang
- Chairman, Directors, Nomination Committee Members, Chairman of the Strategy and Investment Committee, Member of the Performance Appraisal and Remuneration Committee, Acting Secretary to the Board
- --
- yanlin he
- Directors, Deputy General Manager
- --
- yana liu
- Directors, Deputy General Manager
- --
- jinglin sun
- Directors, Member of the Strategy and Investment Committee, Member of the Audit and Risk Management Committee
- --
- mu zhang
- Independent Directors, Member of the Audit and Risk Management Committee, Chairman of the Nomination Committee, Member of the Strategy and Investment Committee
- 140.00K
- yan fang
- Independent Directors, Member of the Audit and Risk Management Committee, Nomination Committee Members, Chairman of the Performance Appraisal and Remuneration Committee
- 240.00K
- fenling gu
- Independent Directors, Chairman of the Audit and Risk Management Committee, Member of the Performance Appraisal and Remuneration Committee
- 240.00K
- jian chen
- Chairman of the Supervisory Board, Shareholder Supervisors
- --
- tan cheng
- Auditors
- --
- hongqing wang
- Chief Financial Officer
- 39.20K
- xiang ci
- General Counsel, Chief Compliance Officer
- --
- jianming wang
- Employee Supervisors
- --
No Data
